Stuart Cobb, Chief Officer of Neurogene NGNE, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $141.4K. The latest trade was on 03/13.

SC

SC

Stuart Cobb

Chief Scientific Officer

Company

Neurogene NGNE

First filing

24/03/14

Trades

9 trades

Buys / sales

0 / 4

12-month net buying

−$141.4K

Last trade

03/13

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
NeurogeneNGNE	Open-market sale10b5-1 plan	03/13	03/17	6,797 sh3 trades	$20.81avg.	$141,445.87	−18.2%
NeurogeneNGNE	Open-market sale10b5-1 plan	25/05/14	25/05/15	6,797 sh	$15.15	$102,974.55	−24.6%